This week on MedHeads, Stephanie Baum will be joined by Meghana Keshavan and Neil Versel to discuss some of the impact of some exciting news when artificial intelligence meets drug development and other hot topics from this week.
Meghana touched base with University of Toronto spinout Deep Genomics. The company has combined deep machine learning techniques with artificial intelligence to study the human genome. It’s creating a database in which users enter patients’ mutations and it will use that information to predict the likelihood of patients developing a disease.
There has also been much debate over whether or not mobile health is an outdated term compared with, say, digital health. At the World Congress’ annual mHealth + Telehealth World Neil covered this week, he found even though some think the world of mobile health is dead as a doorknob, many of the attendees there don’t think the fight is over yet.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
These topics, as well as the beyond the pill milestone of Propeller Health’s latest FDA clearance and other important news from the week that was in healthcare, are on deck for MedHeads at 4 pm Eastern today on Google+ and the embed below.
MedHeads is MedCityNews.com’s weekly broadcast looking back at the week that was in the business of healthcare innovation. In these broadcasts, we’ll take the news seriously but won’t take ourselves too seriously.
